OrbiMed’s Cardinal Health CAH Stock Holding History

OrbiMed’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-166,000	Closed	-$12.9M	–	142
2016 Q2	$12.9M	Hold	166,000	–	–	0.14%	87
2016 Q1	$13.6M	Buy	166,000 +20,000	+14%	+$1.63M	0.14%	75
2015 Q4	$13M	Hold	146,000	–	–	0.12%	82
2015 Q3	$11.2M	Hold	146,000	–	–	0.11%	89
2015 Q2	$12.2M	Sell	146,000 -814,000	-85%	-$71.9M	0.1%	99
2015 Q1	$86.7M	Buy	960,000 +635,000	+195%	+$54.7M	0.74%	42
2014 Q4	$26.2M	Buy	325,000 +48,000	+17%	+$3.79M	0.25%	64
2014 Q3	$20.8M	Hold	277,000	–	–	0.22%	75
2014 Q2	$19M	Buy	277,000 +10,000	+4%	+$681K	0.22%	65
2014 Q1	$18.7M	Buy	267,000 +36,700	+16%	+$2.55M	0.23%	68
2013 Q4	$15.4M	Buy	230,300 +41,000	+22%	+$2.51M	0.23%	70
2013 Q3	$9.87M	Hold	189,300	–	–	0.18%	78
2013 Q2	$8.94M	Buy	+189,300	New	+$8.65M	0.19%	81

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed's CAH Position: Q3 2016 in Review

OrbiMed sold out of Cardinal Health (CAH) in Q3 2016, closing a stake of 166,000 shares — an estimated $12.9M sold.

OrbiMed first reported a position in CAH in Q2 2013 and held it in 13 quarters. The position peaked at $86.7M in Q1 2015. 772 funds tracked by Wall St. Rank hold CAH as of Q3 2016.

OrbiMed reported no remaining Cardinal Health position as of Q3 2016 after selling out during the quarter.
OrbiMed sold 166,000 Cardinal Health shares in Q3 2016, an estimated $12.9M.
OrbiMed first reported a position in Cardinal Health in Q2 2013 and held it in 13 quarters.
OrbiMed's Cardinal Health position peaked at $86.7M in Q1 2015.
772 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2016.

Based on OrbiMed's 13F filing for Q3 2016, filed 14 Nov 2016.